{"id":19034,"date":"2025-05-20T14:13:46","date_gmt":"2025-05-20T20:13:46","guid":{"rendered":"https:\/\/plasmaenergysolution.com\/?p=19034"},"modified":"2025-05-20T15:16:30","modified_gmt":"2025-05-20T21:16:30","slug":"fungal-infection-in-the-brain-produces-effects-similar-to-alzheimers-plus-ivermectin-and-fenbendazole-testimonials","status":"publish","type":"post","link":"https:\/\/plasmaenergysolution.com\/?p=19034","title":{"rendered":"Fungal Infection in the Brain Produces Effects Similar to Alzheimer’s Plus Ivermectin and Fenbendazole Testimonials"},"content":{"rendered":"\n

DEMENTIA & ALZHEIMER’S CURE:<\/strong> Fungal Infection in the Brain Produces Effects Similar to Alzheimer’s. Some researchers have suggested that neurodegenerative diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis may have a microbial origin; thus, inexpensive repurposed <\/em>drugs may be the cure.<\/p>\n\n\n

\n
\"woman
Photo by Andrea Piacquadio on Pexels.com<\/a><\/figcaption><\/figure>\n<\/div>\n\n\n

A recent article by The Epoch Times<\/em> posited that fungal infections may be the cause of neurodegenerative diseases.<\/strong><\/p>\n\n\n\n

A team of researchers at Baylor College of Medicine has discovered that when the brain is infected with a common fungus, it changes in ways similar to those seen in Alzheimer\u2019s disease. The new research<\/u><\/a> delves deeper into some of the molecular mechanisms behind that process.<\/p>\n\n\n\n

The Study Findings<\/strong><\/p>\n\n\n\n

Using animal models, the research team discovered how the fungus, called Candida albicans<\/strong> (C. albicans)<\/strong>, enters the brain, activates mechanisms for its clearance, and generates amyloid beta (A\u03b2)-like peptides\u2014toxic protein fragments thought to be central to the development of Alzheimer\u2019s disease.<\/strong><\/p>\n\n\n\n

The findings were published<\/u><\/a> Oct. 10 in the journal Cell Reports<\/em><\/strong>.<\/p>\n\n\n\n

Previous research has implicated fungi in the development of chronic neurodegenerative diseases like Alzheimer\u2019s disease, but their mechanisms are not entirely understood.<\/p>\n\n\n\n

We know that Candida thrives on sugars, so diets high in processed foods and junk foods may very well be feeding the funguses that in turn destroy brains.<\/strong><\/p>\n\n\n\n

We also know that the inexpensive and repurposed drug Fenbendazole<\/u><\/a> (Mebendazole being the analog drug with the addition of a single molecule which adds nothing save for bogus patent-based profits) eradicates these funguses; for example, a research study entitled, The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against <\/u>Cryptococcus neoformans<\/strong><\/u><\/em><\/a> stated the following:<\/p>\n\n\n\n

\n

Cryptococcus neoformans<\/strong><\/em> is the most lethal pathogen of the central nervous system. The gold standard treatment of cryptococcosis, a combination of amphotericin B with 5-fluorocytosine<\/strong>, involves broad toxicity, high costs, low efficacy, and limited worldwide availability. Although the need for new antifungals is clear, drug research and development (R&D) is costly and time-consuming. Thus, drug repurposing is an alternative to R&D and to the currently available tools for treating fungal diseases. Here we screened a collection of compounds approved for use in humans seeking for those with anti-cryptococcal activity. We found that benzimidazoles<\/strong> consist of a broad class of chemicals inhibiting C. neoformans<\/em> growth. Mebendazole and fenbendazole were the most efficient antifungals showing in vitro<\/em> fungicidal activity<\/strong>. Since previous studies showed that mebendazole reaches the brain in biologically active concentrations, this compound was selected for further studies. Mebendazole showed antifungal activity against phagocytized C. neoformans<\/em><\/strong>, affected cryptococcal biofilms profoundly and caused marked morphological alterations in C. neoformans<\/strong><\/em>, including reduction of capsular dimensions. Amphotericin B and mebendazole had additive anti-cryptococcal effects. Mebendazole was also active against the C. neoformans<\/em> sibling species, C. gattii<\/em>.<\/strong> To further characterize the effects of the drug a random C. gattii<\/em> mutant library was screened and indicated that the antifungal activity of mebendazole requires previously unknown cryptococcal targets. Our results indicate that mebendazole is as a promising prototype for the future development of anti-cryptococcal drugs.<\/strong><\/p>\n<\/blockquote>\n\n\n\n

Thus, we may extrapolate that Fenbendazole<\/u><\/a>, being a powerful antifungal, may quickly and permanently reverse these kinds of neurodegenerative diseases, especially since, \u201c\u2026mebendazole reaches the brain in biologically active concentrations\u2026<\/strong>\u201d<\/em><\/p>\n\n\n\n

And precisely because C. albicans has been shown to generate toxic protein fragments like amyloid beta (A\u03b2)-like peptides in the brain, Fenbendazole<\/u><\/a> would be an especially strong candidate for potential therapeutic use in Alzheimer’s treatment.<\/p>\n\n\n\n

Back to The Epoch Times article, which reinforces this notion of fungal-induced cognitive decline:<\/strong><\/p>\n\n\n\n

Humans and C. albicans have a complicated relationship<\/u><\/a>, as most of the time, C. albicans is harmless and is simply a member of a healthy microbiota. However, it is one of the few fungal species that cause disease in humans and is responsible for infections that range from superficial infections of the mucosa and skin, like thrush, diaper rash, and vaginal yeast infections, to more serious infections like invasive candidiasis that can affect the blood, heart, brain, and bones.<\/p>\n\n\n\n

Infections by C. albicans are particularly dangerous for those with compromised immune systems, like those with AIDS, or people undergoing immunosuppressive therapies for cancer and other conditions. This suppression of the body\u2019s defenses is part of the reason why some people acquire C. albicans infections after taking antibiotics, as they decrease the beneficial bacteria in the gut, causing an imbalance and allowing C. albicans to thrive. C. Albicans can survive outside the body<\/u><\/a> and have the ability to colonize every human organ and tissue. According to the Encyclopedia of Microbiology<\/u><\/a>, it is the most common cause of systemic fungal infections.<\/p>\n\n\n\n

Since so much of humanity is now suffering from (subclinical) VAIDS, infections by C. albicans will become far more prevalent, as will the associated cases of Modified mRNA \u201cvaccine\u201d-induced early onset dementia and Alzheimer’s.<\/strong><\/p>\n\n\n\n

In a January review<\/u><\/a> published in Frontiers in Immunology<\/strong><\/em>, researchers examined the role of fungus in central nervous system autoimmune and neurodegenerative disorders. The review states that recently, increasing evidence has pointed to the role of peripheral fungus in triggering inflammation, immune response, and worsening of a range of non-infectious disorders of the central nervous system (CNS), including multiple sclerosis, Parkinson\u2019s, and Alzheimer\u2019s disease.<\/p>\n\n\n\n

The review concluded that fungus can trigger inflammation via different mechanisms in the progression of CNS non-infectious diseases, suggesting that it is crucial for developing future therapeutic agents and strategies.<\/p>\n\n\n\n

A 2015 study<\/u><\/a> published in Scientific Reports states that several researchers have proposed the possibility that Alzheimer\u2019s disease may have a microbial cause. The researchers found evidence that tissue from the central nervous system (which includes the brain and spinal cord) of patients with Alzheimer\u2019s disease contains fungal cells. These fungal cells were found in different regions of the brain, including the external frontal cortex, cerebellar hemisphere, entorhinal cortex\/hippocampus, and choroid plexus. These fungal materials were not present in the control individuals who did not have Alzheimer\u2019s disease. The researchers identified several different species of fungus in their samples.<\/p>\n\n\n\n

What is of particular note are the surges of both blood clots and immunocompromisation coinciding with the DEATHVAX\u2122 rollout, and the consequent increases of fungal infection susceptibility contributing to ever more deadly outcomes:<\/p>\n\n\n\n

Interestingly, the study authors noted that fungal infection was also found in the blood vessels, which could explain the vascular pathology that is often found in Alzheimer\u2019s patients.<\/p>\n\n\n\n

Once again, the confluence of \u201cvaccine\u201d adverse events is truly curious.<\/p>\n\n\n\n

The findings provide intriguing evidence that these fungal infections are present in the central nervous systems of those with Alzheimer\u2019s disease and not in healthy individuals who served as the controls.<\/p>\n\n\n\n

Given that over time the slow kill bioweapon injections render increasingly larger swaths of unhealthy individuals, the unvaccinated healthy individuals will serve as the ultimate controls, especially for increasingly prevalent diseases such as dementia and Alzheimer\u2019s.<\/p>\n\n\n\n

Another Piece of the Puzzle<\/strong><\/p>\n\n\n\n

Dr. Corry and his colleagues have provided another piece to further understand the role fungus may play in the development of Alzheimer\u2019s disease.<\/p>\n\n\n\n

\n

\u201cThis work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer\u2019s disease,\u201d Corry said in a press release. \u201cThe current explanation for this condition is that it is mostly the result of the accumulation of toxic A\u03b2-like peptides in the brain that leads to neurodegeneration. The dominant thinking is that these peptides are produced endogenously [internally], our own brain proteases break down the amyloid precursor proteins generating the toxic Ab peptides.\u201d<\/p>\n<\/blockquote>\n\n\n\n

Due to their anti-prion activity, the other pieces of the therapeutic puzzle are Ivermectin<\/u><\/a> and Quercetin.<\/strong><\/p>\n\n\n\n

Ivermectin<\/strong><\/u><\/a>, another antiparasitic drug, was shown by Kawasaki et al. (2007) to have prevented the formation of the infectious form of the prion protein in prion-infected cells. Meanwhile, Quercetin,<\/strong> a flavonoid, extended the lifespan of prion-infected mice, highlighting its therapeutic potential against prion diseases.<\/p>\n\n\n\n

Both compounds have also exhibited properties that modulate tauopathy, a characteristic of Alzheimer’s disease. Ivermectin<\/u><\/a> inhibited tau hyperphosphorylation and even disaggregated tau fibrils. Quercetin, too, displayed capabilities against tauopathy by inhibiting the hyperphosphorylation of the tau protein.<\/p>\n\n\n\n

The discovery of Fenbendazole<\/u><\/a>, Ivermectin<\/u><\/a>, and Quercetin’s potential therapeutic properties underscores the importance of repurposing existing drugs in order to create highly accessible new treatment paradigms for neurodegenerative diseases.<\/strong><\/p>\n\n\n\n

\u2026end of article.<\/p>\n\n\n\n

Video:<\/strong> Why Should You Care About Fungal Infections Of The Brain?<\/strong><\/p>\n\n\n

\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n

https:\/\/www.brighteon.com\/b6d246bc-4cbd-43c8-8237-2471c771bb21<\/a><\/p>\n\n\n\n

Lynn shares information regarding fungal infections of the brain that are mimicking brain disorders. Baylor College of Medicine has discovered that when the brain is infected with a common fungus, it changes in ways similar to those seen in Alzheimer\u2019s disease. Find out why Lynn is talking about Parasites and Kan-Sir Plus at the same time.<\/p>\n\n\n\n

An Important Special From Plasma Energy Solution:<\/strong><\/p>\n\n\n\n

May 2025 Special…Ends May 31,2025 Midnight PST<\/strong><\/p>\n\n\n\n

Choose a product from one of these groups then select a free choice from the same <\/em>group<\/strong><\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

Notice<\/strong> the special above offers Kan-Sir Plus<\/em><\/strong>\u2026purchase one in the group and get another free\u2026<\/p>\n\n\n\n

Why is Kan-Sir Plus<\/em><\/strong> so important? <\/p>\n\n\n\n

It includes the energies of Fenbendazole<\/strong> and Ivermectin<\/strong> along with many other energies\u2026<\/p>\n\n\n\n

Video: It\u2019s For Parasites In Animals So Why Would People Want It?<\/strong>   <\/p>\n\n\n

\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n

Find out why Lynn is talking about Parasites and Kan-Sir Plus at the same time.<\/p>\n\n\n\n

Video: <\/strong> Dr. Peter McCullough<\/strong> Interview<\/strong><\/p>\n\n\n

\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n

Now read why these energies are so important:<\/strong><\/p>\n\n\n\n

IVERMECTIN and FENDBENDAZOLE Testimonials:<\/strong><\/p>\n\n\n\n

Cancer Free After 12 months<\/strong><\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n

https:\/\/www.thefocalpoints.com\/p\/combination-ivermectin-mebendazole?publication_id=1119676&post_id=162408308&r=x4m1&triedRedirect=true<\/a><\/p>\n\n\n\n

Stage 2 Fallopian Tube Cancer, Stage 4 Breast Cancer With Lymph Node And Bone Metastases, 3 Months To Live Stomach Tumor<\/strong><\/a><\/p>\n\n\n\n

In this Substack\u2019s ongoing anecdotal repurposed drug crowdsourcing series comes another trio of absolutely incredible healing experiences courtesy of Dr. Makis. The first case involved the administration of the dubious and dangerous chemotherapy \u201ctreatment\u201d combined with Ivermectin<\/a> and Fenbendazole<\/a>, and we can be all but certain that the only reason the patient is now in full remission is strictly due to the miraculous synergistic<\/a> repurposed drugs:<\/p>\n\n\n\n

63 year old patient with a high grade serous Fallopian Tube Cancer asked me for help. They put her on chemo but we implemented: Ivermectin<\/a> 1mg\/kg\/day escalating to 2mg\/kg\/day<\/strong> Fenbendazole<\/a> 444mg\/day to 1332mg\/day<\/strong><\/p>\n\n\n\n

A month after starting Ivermectin<\/a>\/Fenbendazole<\/a> Protocol she had surgery and had some cancer cells in the abdominal wash. She restarted the Ivermectin<\/a>\/Fenbendazole<\/a> Protocol. A few weeks later during HIPEC surgery, they couldn’t find any cancer cells. <\/p>\n\n\n\n

Here is the patient’s recounting of the story:<\/strong><\/p>\n\n\n\n

“I saw the hematologist yesterday and he said no one at the tumor board could understand why the fluid showed no cancer.”<\/p>\n\n\n\n

“He said in his whole career he has never seen anything like it. So rare to see such a thing. Then I told him that I went on Ivermectin<\/a> and he laughed. He hopes @RobertKennedyJr<\/a> can get this legalized in the states and that I should share this news with the other doctors and surgeon that performed this surgery. He said his other patients are taking Ivermectin<\/a> with chemo now.”<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n

The doctor has never seen anything like it in his entire career, and yet he will still administer chemotherapy which he has seen his entire career kill off the majority of his patients. This is the splitting of the difference of his career-long Medical Industrial Complex indoctrinated CogDis, and precisely why oncologists will increasingly add Ivermectin<\/a> to their chemotherapy \u201ctreatments\u201d because they can continue to extract astronomical profit margins from the latter, while actually now curing patients with the former; in other words, the Ivermectin<\/a> will be used as both the cover and the cure for their deadly legacy allopathic treatments going forward.<\/p>\n\n\n\n

The next case appears to have been an especially aggressive turbo cancer that required higher dosing protocols, but did not involve chemotherapy which further reinforces the aforementioned point that the Ivermectin<\/a> and Fenbendazole<\/a> are responsible for the remission, not the Medical Industrial Complex poisons; to wit:<\/p>\n\n\n\n

STORY:<\/strong> 51 year old Canadian patient was diagnosed with Stage 4 Breast Cancer metastatic to lymph nodes and bones on Aug.2, 2024.<\/strong><\/p>\n\n\n\n

Makis Ivermectin Cancer Clinic Protocol was started in mid-August: Ivermectin<\/a> 1mg\/kg\/day increasing to 2mg\/kg\/day<\/strong> Fenbendazole<\/a> 888mg\/day<\/strong><\/p>\n\n\n\n

RESULTS after 5 months on <\/strong>Ivermectin<\/a> Protocol:<\/strong> -CA 15-3: 1386 to 94 (93% drop) (!!)<\/strong> CT Scan: <\/strong>– Previous 5cm breast mass is smaller (hard to delineate from background) – axillary lymph nodes slightly smaller – lung nodules nearly completely resolved (!) – bone metastases not commented on (bone scan showed decreased and more diffuse uptake consistent with treatment response)<\/p>\n\n\n\n

My Take\u2026 51 year old Stage 4 Breast Cancer patient had the following results after 5 months of Ivermectin<\/a> Protocol (Ivermectin 96mg, <\/strong>Fenbendazole<\/a> 888mg<\/strong>)<\/p>\n\n\n\n

Conventional treatments: no chemo, <\/strong>2 shots of Zoladex and 2x radiation to spine and femur. Patient refused Letrozole and Kisqali (ribociclib)<\/p>\n\n\n\n

CA 15-3: 1386 to 94 (93% drop) (!!)<\/strong> CT Follow-up: Breast tumor, axillary nodes, lung nodules all shrinking and bone metastases healing<\/p>\n\n\n\n

It wasn\u2019t without a few challenges along the way We\u2019ve had to deal with a couple of asymptomatic episodes of elevated liver function tests. Patient is taking a lot of supplements. But this has been a stunning response to treatment and an incredible success story!<\/strong><\/p>\n\n\n\n

<\/blockquote>\n\n\n\n

NEVER ENDING PLASMA ENERGY KAN-SIR PLUS\u2026what is in it and how do you use it?<\/strong><\/p>\n\n\n\n

\t\t
\n\t\t\t